Features of the development of the COVID-19 pandemic

Relevance. At the end of 2019, an outbreak of a new coronavirus infection occurred in the People's Republic of China with an epicenter in Wuhan. On February 11, 2020, the World Health Organization assigned the infection its official name -COVID-19 («Coronavirus disease 2019»), and the International Committee on Taxonomy of Viruses on February 11, 2020 assigned the official name to the causative agent - SARS-CoV-2. The study is relevant due to the fact that the disease quickly spread around the planet with the active drift of the pathogen into the territory of the Russian Federation. As of 11/26/2020, worldwide 60 million 894 thousand people were infected with COVID-19, 1 million 430 thousand died, 42 million 90 thousand people recovered.
Intention. Analysis of publications on the epidemiological spread of COVID-19 for the purpose of effective medical and psychological support during dynamic monitoring of the disease, and also for epidemiological well-being.
Methodology. Scientific publications from domestic and foreign databases were analyzed.
Results and Discussion. The global and rapid spread of COVID-19 disease has had a huge impact on all healthcare sectors around the world and has expanded the existing understanding of the nature of the course of this disease, and greatly facilitated the diagnosis, treatment and prevention of new coronavirus infection. The paper discusses the main issues of epidemiology, laboratory diagnostics and prevention of COVID-19, which are currently relevant. In the future, the massive use of vaccines against the new coronavirus will help create population immunity and protect the population from this disease, but today the issue has not yet been resolved, although it should be resolved in the near future.
Conclusion. The issues of epidemiology and laboratory diagnostics of COVID-19 have not yet been finally resolved. The measures taken in Russia to prevent the import of HV are undoubtedly important and adequate to the current situation. At the same time, they cannot completely prevent cases of virus spreading (by those in the incubation period of COVID-19, or those with latent and hidden disease), which can lead to probable epidemiological problems in the future.

1. Bryndin E.G., Bryndina I.E. Dukhovno-naturalisticheskiye aspekty bezopasnosti naseleniya ot COVID-19 [Spiritual and naturalistic aspects of population security from COVID-19]. Faktory riska, populyatsionnoe (individual'noe) zdorov'e v gigienicheskoi donozologicheskoi diagnostike [Risk factors, population (individual) health in hygienic prenosological diagnostics] : Scientific. Conf. Proceedings. Sankt-Peterburg. 2020. Pp. 125-128. (In Russ.)

2. Varnavskaia E.V., Afanasyev S.O., Yakovenko N.S. Lexitcheskiye marker sotsialnoy trevozhnosti [Lexical markers of social anxiety]. Internat. J. Humanities and Natur. Sci. 2020. Vol. 7-3. Pp. 62-64. DOI:10.24411/2500-1000-2020-10813. (In Russ.)

3. Varfalovskaya R.A., Varfalovskiy A.V. Upravlencesliye reshenia KNR v usloviyakh globalnogo zarazhenia COVID-19 [Management decisions of the PRC under the conditions of global infection of COVID-19]. Obrazovanie i pravo [Education and Law]. 2020. N 4. Pp. 418-422. DOI:10.24411/2076-1503-2020-10465. (In Russ.)

4. Vremennye algorytmy po vedeniyu patsientov s novoy koronarovirusnoy infekciyey COVID-19 v pereprofilirovannykh klinilakh akademii [Temporary algorithms for the management of patients with the new coronavirus infection COVID-19 in the repurposed academy clinics. Version from 25.04.2020]. Sankt-Peterburg. 2020. 20 p. (In Russ.)

5. Vremennye metodicheskie rekomendatsii. Issledovanie umershikh s podozreniem na koronavirusnuyu infektsiyu (COVID-19). Versiya ot 28.03.2020 g [Temporary guidelines «Study of deaths with suspected coronavirus infection (COVID-19). Version from 28.03.2020]. Moskva. 2020. 65 p. (In Russ.)

6. Vremennye metodicheskie rekomendatsii. Issledovanie umershikh s podozreniem na koronavirusnuyu infektsiyu (COVID-19). [Temporary guidelines «Study of deaths with suspected coronavirus infection (COVID-19). Version from 24.04.2020]. Moskva. 2020. 142 с. (In Russ.)

7. Vremennye metodicheskie rekomendatsii. Issledovanie umershikh s podozreniem na koronavirusnuyu infektsiyu (COVID-19). [Temporary guidelines «Study of deaths with suspected coronavirus infection (COVID-19). Version from 26.10.2020]. Moskva. 2020. 236 с. (In Russ.)

8. Zhdanov K.V., Kozlov K.V., Bulan'kov Yu.I. [et al.]. Optimizatsiya diagnostiki infektsii, vyzvannoi SARS-CoV-2, s ispol'zovaniem polimeraznoi tsepnoi reaktsii v krupnom mnogoprofil'nom statsionare [Optimization of diagnosis of SARS-CoV-2 infection using polymerase chain reaction in a large multi-specialty hospital]. Vestnik Rossiiskoi Voenno-meditsinskoi akademii [Bulletin of Russian Military medical Academy]. 2020. N 2. Pp. 7-10. (In Russ.)

9. Ivashkin V.T., Kotel'nikov S.N., Stepanov E.V. Vozmozhnoe usilenie tyazhesti protekaniya COVID-19 za schet cochetannogo deistviya virusa SARS-COV-2 i ozona pri sezonnom povyshenii soderzhaniya ozona v prizemnoi atmosfere [Possible increase in the severity of COVID-19 due to the combined action of the SARS-COV-2 virus and ozone with a seasonal increase in the ozone content in the surface atmosphere]. Faktory riska, populyatsionnoe (individual'noe) zdorov'e v gigienicheskoi donozologicheskoi diagnostike [Risk factors, population (individual) health in hygienic prenosological diagnostics] : Scientific. Conf. Proceedings. Sankt-Peterburg. 2020. Pp. 277-280. (In Russ.)

10. Kashkin S.Yu., Tishchenko S.A., Altukhov A.V. Pravovoe regu-lirovanie primeneniya iskusstvennogo intellekta dlya bor'by s raspros-traneniem COVID-19: problemy i perspektivy s uchetom mirovogo opyta [Legal Regulation of the Artificial Intelligence Application for Combatting the Spread of COVID-19: Problems and Prospects based on World Experience]. Lex Russica. 2020. Vol. 73, N 7. Pp. 105-114. DOI:10.17803/17295920.2020.164.7.105-114. (In Russ.)

11. Kostinov M.P., Svitich O.A., Markelova E.V. Potencialnaya immunoprofilaktika COVID-19 u grupp vysokogo riska inficirovania [Potential COVID-19 immunization in high-risk groups]. Moskva. 2020. 64 p. (In Russ.)

12. Kuznetsova N.A., Pochtovyi A.A., Nikiforova M.A., Gushchin V.A. Strategii dizaina RT-PTsR-sistem i organizatsiya monitoringa SARS-COV-2 [Strategies of RT-PCR-based assay design and surveillance of SARS-COV-2]. Vestnik Rossiiskogo gosudarstvennogo meditsinskogo universiteta [Bulletin of the Russian state medical university : Bulletin of RSMU]. 2020. N 2. Pp. 19-22. (In Russ.)

13. Metodicheskiye rekomendatcii po kodirovaniyu I vyboru osnovnogo sostoyania v statistike zabolevaemosti I pervonatchalnoy pritciny v statistike smertnosti, sviazannye s COVID-19 (utverzhdeny zamestitelem ministra zdravookhranenia Rossiyskoy Federatcii 27.05.2020 г.) [Methodological recommendations for coding and choosing the main condition in the statistics of morbidity and the initial cause in the statistics of mortality associated with COVID-19 (approved by the Deputy of the Ministry of Health of the Russian Federation on May 27, 2020)]. Moskva, 2020. 24 p. (In Russ.)

14. Osidak L.V., Muradyan A.Ya., Rumel' N.B., Drinevskii V.P. Koronavirusnaya infektsiya (etiologiya, epidemiologiya, kliniko-laboratornaya kharakteristika, protivovirusnaya terapiya) [Coronavirus infection (etiology, epidemiology, clinical and laboratory characteristics, antiviral therapy)]. Sankt-Peterburg. 2007. 64 p. (In Russ.)

15. O napravlenii dlya ispol'zovaniya v rabote rekomendatsii po voprosam organizatsii psikhologicheskoi i psikhoterapevticheskoi pomoshchi v svyazi s rasprostraneniem novoi koronavirusnoi infektsii COVID-19 : pis'mo Minzdrava Rossii ot 07.05.2020 g. № 28-3/I/2-6111 [On the direction for use in the work of recommendations on the organization of psychological and psychotherapeutic assistance in connection with the spread of the new coronavirus infection COVID-19 : Letter of the Ministry of Health of the Russian Federation of 07.05.2020, N 28-3/I/2-6111]. Moskva. 2020. 20 p. (In Russ.)

16. Pashenkov M.V., Khaitov M.R. Immunniy otvet protiv epide-mitcheskikh koronavirusiv [Immune response against epidemic coronaviruses]. Immunologia [Immunology]. 2020. Vol. 41, N 1. P. 5-18. (In Russ.)

17. Perechen' zabolevanii (sindromov) ili oslozhnenii, vyzvannykh podtverzhdennoi laboratornymi metodami issledovaniya novoi korona-virusnoi infektsii (COVID-19), vyzvavshikh prichinenie vreda zdorov'yu otdel'nykh kategorii lits, predusmotrennykh Ukazom Prezidenta Rossiiskoi Federatsii ot 6 maya 2020 g. № 313 «O predostavlenii dopolnitel'nykh strakhovykh garantii otdel'nym kategoriyam meditsinskikh rabotnikov», i povlekshikh za soboi vremennuyu netrudosposobnost', no ne privedshikh k invalidnosti (utverzhdeno rasporyazheniem Pravitel'stva Rossii ot 15 maya 2020 g. № 1272-r) [The list of diseases (syndromes) or complications caused by laboratory-confirmed new coronavirus infection (COVID-19), which caused harm to the health of certain categories of persons provided for by the Decree of the President of the Russian Federation dated May 6, 2020 N 313 «On the provision of additional insurance guarantees to certain categories of medical workers», and entailed temporary disability, but did not lead to disability (approved by the order of the Government of the Russian Federation dated May 15, 2020 N 1272-р)]. Moskva. 2020. 3 p. (In Russ.)

18. Poriadki deystviy medicinskikh rabotnikov na ambulatornom etape okazania pomoshi v usloviyakh epidemii COVID-19, razrabotannye na osnove deystvuyuchikh normativnykh dokumentov po voprosam protivodeystvia rasprostraneniya koronavirusnoy ingekcii v Rossiyskoy Federacii [Procedures for the actions of medical workers at the outpatient stage of providing care in the context of the COVID-19 epidemic, developed on the basis of the current regulatory documents on countering the spread of coronavirus infection in the Russian Federation]. Moskva. 2020. 28 p.

19. Ob utverzhdenii sanitarno-epidemiologicheskikh pravil SP 3.1.3597-20 «Profilaktika novoi koronavirusnoi infektsii (COVID-19)»: postanovlenie Glavnogo gosudarstvennogo sanitarnogo vracha Rossii ot 22.05.2020 g. № 15 [On approval of the sanitary and epidemiological rules of SP 3.1.3597-20 “Prevention of a new coronavirus infection (COVID-19) : Decree of the Chief State Sanitary Doctor of the Russian Federation of May 22,05.2020 N 15]. Rossiiskaya gazeta : federal'nyi vypusk [Russian newspaper]. N 115. 29.05.2020. (In Russ.)

20. Andersen K.G., Rambaut A., Lipkin W.I. [et al.]. The proximal origin of SARS-CoV-2. Nat Med. 2020. Vol. 26, N 4. Pp. 450-452. DOI: 10.1038/s41591-020-0820-9.

21. Baltimore D. Expression of animal virus genomes. Bacteriol. Rev. 1971. Vol. 35, N 3. Pp. 235-241. PMID 4329869.

22. Behrens E.M., Koretzky G.A. Review: Cytokine Storm Syndrome: Looking Toward the Precision Medicine Era. Arthritis Rheumatology. 2017. Vol. 69, N 6. P. 1135-1143. DOI:10.1002/art.40071.

23. Carlos W.G., Dela Cruz C.S. [et al.]. Novel Wuhan (2019-nCoV) coronavirus. Am. J. Respir. Crit. Care Med. 2020. Vol. 201, N 4. Pp. 7-8. DOI:10.1164/rccm.2014P7.

24. Casas C., Catala A., Hern6ndez G. [et al.]. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br. J. Dermatol. 2020 Vol. 183, N 1. Pp. 71-77. DOI: 10.1111/bjd.19163.

25. Chen W., Lan Y., Yuan X., [et al.]. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerg. Microbes Infect. 2020. Vol. 9, N 1. P. 469-473. DOI:10.1080/22221751.2020.1732837.

26. Chen Y.C., Huang L.M., Chan C.C. [et al.]. SARS Research Group of National Taiwan University College of Medicine and National Taiwan University Hospital. SARS in hospital emergency room. Emerg. Infect. Dis. 2004. Vol. 10, N 5. Pp. 782-788. DOI:10.3201/eid1005.030579.

27. Chien J.Y., Hsueh P.R., Cheng W.C. [et al.]. Temporal changes in cytokine/chemokine profi les and pulmonary involvement in severe acute respiratory syndrome. Respirology. 2006. Vol. 11, N 6. P. 715-722. DOI: 10.1111/j.1440-1843.2006.00942.x.

28. Contentti E.C., Correa J. Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge. Mult. Scler. Relat. Disorder. 2020. N 41. P. 102097. DOI:10.1016/j.msard.2020.102097.

29. Day M. COVID-19: four fifths of cases are asymptomatic, China figures indicate. BMJ. 2020. N 369. Art. m1375. DOI:10.1136/bmj.m1375.

30. Decaro N., Martella V., Saif L.J., Buonavoglia C. COVID-19 from veterinary medicine and one health perspectives: What animal coronaviruses have taught us. Res. Vet. Sci. 2020. N 131. Pp. 21-23. DOI:10.1016/j.rvsc.2020.04.009.

31. Enjuanes L., Zuciga S., Castaco-Rodriguez C. [et al.]. Molecular Basis of Coronavirus Virulence and Vaccine Development. Adv. Virus Res. 2016. N 96. Pp. 245-286. DOI:10.1016/bs.aivir.2016.08.003.

32. Goh G.K.-M., Dunker A.K., Foster J.A., Uversky V.N. Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids. Microb. Pathog. 2020. N 144. Art. 104177. DOI:10.1016/j.mic-path.2020.104177.

33. Gualano G., Musso M., Mosti S. [et al.]. Usefulness of bronchoalveolar lavage in the management of patients presenting with lung infiltrates and suspect COVID-19-associated pneumonia: A case report. Int. J. Infect. Dis. 2020. N 97. Pp. 174-176. DOI:10.1016/j.ijid.2020.05.027.

34. Huang C., Wang Y., Li X. [et al.]. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020. Vol. 395, N 10223. Pp. 497-506. DOI: 10.1016/S0140-6736(20)30183-5.

35. Jahan Y., Rahman S., Rahman A. COVID-19: A Case Report from Bangladesh Perspective. Respir. Med. Case Rep. 2020. N 30. Art. 101068. DOI:10.1016/j.rmcr.2020.101068.

36. Khodadadi E., Maroufi P., Khodadadi E. [et al.]. Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19). Microb Pathog. 2020. N 146. Art. 104241. DOI:10.1016/j.micpath.2020.104241.

37. Laamarti M., Alouane T., Kartti S. [et al.]. Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geo-distribution and a rich genetic variations of hotspots mutations. BioRxiv. 2020. URL: https://www.biorxiv.org/. DOI:10.1101/2020.05.03.074567v1.

38. Lauer S.A., Grantz K.H., Bi Q. [et al.]. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann. Intern. Med. 2020. Vol. 172, N 9. Pp. 577-582. DOI: 10.7326/M20-0504.

39. Petrosillo N., Viceconte G., Ergonul O. [et al.]. COVID-19, SARS and MERS: are they closely related? Clin. Microbiol. Infect. 2020. Vol. 26, N 6. P. 729-734. DOI:10.1016/j.cmi.2020.03.026.

40. Sifuentes-RodrHguez E., Palacios-Reyes D. COVID-19: The outbreak caused by a new coronavirus. Bol. Med. Hosp. Infant. Mex. 2020. Vol. 77, N 2. Pp. 47-53. DOI: 10.24875/BMHIM.20000039.

41. Weiss S.R., Navas-Martin S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol. Mol. Biol. Rev. 2005. Vol. 69, N 4. P. 635-664. DOI: 10.1128/MMBR.69.4.635-664.2005.

42. Zheng H.-Y., Zhang M., Yang C.-X. [et al.]. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cellular and Molecular Immunology. 2020. Vol. 17, N 5. Pp. 541-543. DOI:10.1038/s41423-020-0401-3.